Correction Volume 13, Issue 20 pp 23871

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression

Pol Andrés‐Benito1,2,3, , Raúl Domínguez4, , Maria J. Colomina5, , Franc Llorens2,3, , Mònica Povedano4, , Isidro Ferrer1,2,3,6,7, ,

  • 1 Department of Pathology and Experimental Therapeutics, University of Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
  • 2 Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, L’Hospitalet de Llobregat, Barcelona, Spain
  • 3 Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet de Llobregat, Barcelona, Spain
  • 4 Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
  • 5 Anesthesia and Critical Care Department, Bellvitge University Hospital ‐ University of Barcelona L’Hospitalet de Llobregat, Barcelona, Spain
  • 6 Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain
  • 7 Institute of Neurosciences, University of Barcelona, Barcelona, Spain
https://doi.org/10.18632/aging.203667
How to Cite